US Interleukin Inhibitors market

1. Orion Market Research US Interleukin Inhibitors Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 Request a Free Sample @ https://www.omrglobal.com/request-sample/us-interleukin- inhibitors-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The US Interleukin Inhibitors market is anticipated to grow significantly at a CAGR of 11.0% over the forecast period (2021-2027). The key aspect that drives the growth of the US Interleukin Inhibitors market includes the rise in the prevalence of arthritis, asthma, eczema, inflammatory bowel disease (IBD), psoriasis, and others. According to the Institute for Health Metrics and Evaluation, the prevalence of psoriasis was 4.1 million in 2017 which increased to 4.2 million in 2019. The prevalence of inflammatory bowel disease (IBD) was more than 749,000 which increased to more than 762,000 in 2019. To @ https://www.omrglobal.com/request-sample/us-interleukin-inhibitors-market learn more about this report request a free sample copy Whereas, the prevalence of asthma was 32.6 million in 2017 which increased to 33.9 million in 2019. The rise in the prevalence of such diseases demands for advanced treatment options including interleukin inhibitors, which, in turn, drives the growth of the market. Further, the presence of the key market players operating in the market also drives the growth of the market in the country over the forecast period. Players such as Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck KGaA, AstraZeneca Plc, and Sun Pharmaceutical Industries Ltd. among others contribute to the growth of the market across the country by adopting various growth strategies. Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/us- interleukin-inhibitors-market US Interleukin Inhibitors Market – Segmentation By Product Type IL-1 Inhibitors IL-5 Inhibitors IL-6 Inhibitors IL-17 Inhibitors IL-23 Inhibitors By Applications Arthritis Asthma Eczema Inflammatory Bowel Disease (IBD) Psoriasis Others Company Profiles

3. AbbVie, Inc. AstraZeneca Plc Bausch Health Co. Inc. Bristol–Myers Squibb Co. Eli Lilly and Co. F. Hoffmann-La Roche Ltd. GlaxoSmithKline Plc Johnson and Johnson Services Inc. Merck KgaA Novartis AG For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-interleukin-inhibitors-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404